Press Releases
-
Improving clinical trial diversity
The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.
-
Gummy phlegm and COVID-19
Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.
-
Stanford Medicine provides mpox test
Stanford Medicine now provides a test for the mpox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.
-
COVID vaccine approved for young kids
Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.
-
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
-
‘Anti-hunger’ molecule discovered
Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.
-
1,000+genes linked to severe COVID-19
Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.
-
COVID-19 brain fog similar to chemo brain
Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.
-
Bacteria that digest breast milk in decline
Stanford Medicine researchers and colleagues found that as nations industrialize, a species of bacteria critical in the early development of infant gut microbiomes fades away.
-
Ketogenic diet helps cells survive stress
Muscle stem cells enter a deep resting state during fasting or when fed a high-fat ketogenic diet, a Stanford-led study finds. This promotes stem cell resilience but slows injury repair.